Using Cannabis to Treat Restless Legs Syndrome

Key facts

Sponsor

Sunnybrook Health Sciences Centre

Intervention

Cannabis oil(drug)

Enrollment

30 target

Eligibility

25 years · All sexes

Timeline

2025 – 2027

Study locations (2)

• Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
• University Health Network, Toronto, Ontario, Canada

Collaborators

University Health Network, Toronto

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Primary orthostatic tremor

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07340554
  Neuroimaging of Adolescent Cannabis Use Treatment
  Indiana University
• ACTIVE NOT RECRUITINGNCT07582445
  Perioperative Prospective Follow Up Of Cannabis Consumers and Discrepancy Use
  Hadassah Medical Organization
• RECRUITINGPHASE2NCT07523633
  Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
  Anders Fink-Jensen, MD, DMSci
• ENROLLING BY INVITATIONNANCT07513337
  Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes (Aim 2 Study)
  Johns Hopkins Bloomberg School of Public Health
• RECRUITINGNANCT07056894
  Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis
  Nova Scotia Health Authority
• RECRUITINGNANCT07196462
  Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
  Vanderbilt University Medical Center
• RECRUITINGPHASE3NCT05052541
  Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
  University of Colorado, Denver
• RECRUITINGPHASE1NCT07176208
  Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults
  Food and Drug Administration (FDA)

See all trials for Primary orthostatic tremor →